Manipal Health IPO Set to Surge: GMP Suggests 10% Gains as Healthcare Giant Seeks ₹9,275 Crore Raise

Manipal Health IPO Set to Surge: GMP Suggests 10% Gains as Healthcare Giant Seeks ₹9,275 Crore Raise​

Bengaluru-based Manipal Health Enterprises is preparing for a significant public market debut with its maiden Initial Public Offering (IPO). The company operates the extensive Manipal Hospitals network and aims to raise a substantial sum through the offering. The IPO has been priced in the range of Rs 560 to Rs 590 per share, signaling robust investor confidence in the healthcare sector.

Key Details and Financial Objectives of the Offering​

The Manipal Health Enterprises IPO is designed to raise a total of Rs 9,275 crore. This substantial amount will be raised through a fresh issue component totaling Rs 8,000 crore. Additionally, the offering includes an Offer for Sale (OFS) amounting to 2.16 crore equity shares, valued at Rs 1,275.2 crore.

The company's operations are extensive, claiming it is India’s largest pan-India multispecialty hospital network by bed capacity. It operates 49 hospitals across more than 24 cities and manages over 12,600 beds nationwide. This scale underscores the importance of market visibility for the organization.

IPO Timeline and Investment Opportunities​

The process for the Manipal Health IPO is carefully scheduled. The anchor book opening is set for a single day on July 28. Following this, the public issue will remain open for subscription from July 29 to July 31.

Investors are advised that the allotment is expected to be finalized on August 3. The much-anticipated listing of the company’s shares on the stock exchanges is scheduled for August 5.

Grey Market Premium Analysis and Valuation Indicator​

Based on prevailing market sentiment, the Grey Market Premium (GMP) suggests a strong listing performance for the IPO. At around Rs 645, this GMP implies a potential listing gain of approximately 9.5% over the upper issue price of Rs 590.

It is crucial, however, that investors view the grey market as an unofficial indicator only. The GMP reflects current market sentiment and does not guarantee any specific listing gains for subscribers.

Fund Utilization and Corporate Commitments​

The company has outlined a clear plan for utilizing the net proceeds generated from the fresh issue component of the IPO. A significant portion of the funds, amounting to Rs 5,378 crore, is earmarked for repaying existing borrowings.

Furthermore, Rs 574 crore from the net proceeds will be allocated to acquiring a minority stake in its step-down subsidiary, Sahyadri Hospitals. The remaining allocated funds are reserved for general corporate purposes within the organization.

Participants and Book Running Managers​

The Offer for Sale (OFS) component involves several selling shareholders. These include Imperius Healthcare Investments and Manipal Education and Medical Group India. Other identified selling shareholders are TPG SG Magazine, Seventy Second Investment Company, Ammar Sdn Bhd, Novo Holdings Invest Asia, and Phoenix Bear Investments.

A group of distinguished institutions serve as the book-running lead managers for this offering. These include Kotak Mahindra Capital Company, Axis Capital, Goldman Sachs (India) Securities, Jefferies India, JPMorgan India, UBS Securities India, and DBS Bank India.

Details on Employee Reservations and Subscription Rules​

The IPO includes a specific allocation of shares set aside for employees. Worth Rs 15 crore, these employee-reserved shares will be available at a discount of Rs 56 per share below the final offer price.

For general public investors, there is a minimum subscription requirement of 25 equity shares. Subsequent bids must be placed in multiples of 25 shares.